Comments on:

FDA expands approval of Bayer cancer drug

Back to the article » |
WASHINGTON (AP) — The Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that don't respond to other treatments. The drug is called Stivarga and regulators approved it to treat gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other FDA-approved drugs. The FDA previously approved...

To learn more about commenting on and our community guidelines, please see our comments FAQ.